Skip to content

MiMedx Group MDXG Operating Income

Operating Income at other companies

IAR
Integra LifeSciencesIART
$11.47M+174%
Solventum logo
SolventumSOLV
$81M-46.7%
Vericel logo
VericelVCEL
-$8.06M+37.0%
Enovis logo
EnovisENOV
$6.53M+114%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$1.53M+66.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$373.2M+27.7%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's operating income?
MiMedx Group (MDXG) reported operating income of -$16.05M in Q1 2026.
How has MiMedx Group's operating income changed year-over-year?
MiMedx Group's operating income decreased by 294.5% year-over-year, from $8.25M to -$16.05M.
What is the long-term trend for MiMedx Group's operating income?
Over 2 years (2023 to 2025), MiMedx Group's operating income has grown at a 31.2% compound annual growth rate (CAGR), from $37.11M to $63.89M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.